Putnam Investments’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-180,343
| Closed | -$4.17M | – | 1229 |
|
|
2023
Q1 | $4.17M | Sell |
180,343
-3,000
| -2% | -$69.5K | 0.01% | 479 |
|
|
2022
Q4 | $4.8M | Sell |
183,343
-7,200
| -4% | -$189K | 0.01% | 446 |
|
|
2022
Q3 | $3.75M | Buy |
+190,543
| New | +$3.75M | 0.01% | 511 |
|
|
2022
Q2 | – | Sell |
-33,674
| Closed | -$551K | – | 1241 |
|
|
2022
Q1 | $551K | Buy |
33,674
+1,560
| +5% | +$25.5K | ﹤0.01% | 972 |
|
|
2021
Q4 | $523K | Buy |
+32,114
| New | +$523K | ﹤0.01% | 991 |
|